Patent details

EP2327719 Title: Hybrid and tandem expression of neisserial proteins.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2327719
WO Application Number:
Type:
European Patent Granted for NL
Status:
Revoked
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10179755.3
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Italy (IT)
Publications:

Dates

Filing date:
06/09/2002
Grant date:
20/08/2014
EP Publication Date:
20/08/2014
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
20/08/2014
EP B1 Publication Date:
20/08/2014
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
30/10/2014
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
05/09/2022
Lapsed By Expiration Date:
Revocation Date:
31/05/2017
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
03/05/2017
 
 

 

Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)

Historical Applicant/holder

From:
20/08/2014
To:
03/05/2017

 

Name:
Novartis Vaccines and Diagnostics S.r.l.
Address:
Via Fiorentina 1, 53100 SIENA (SI), Italy (IT)

Inventor

Name:
Pizza, Mariagrazia
Address:
53100 SIENA, Italy (IT)

Priority

Priority Patent Number:
0121591
Priority Date:
06/09/2001
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07K 14/22;
IPC or IDT classification:
A61K 38/16; C12N 15/62;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
30/17
Publication date:
26/07/2017
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
VRV
Journal edition number:
28/17
Publication date:
12/07/2017
Description:
Lapse or annulment

3

Bulletin Heading:
VB2
Journal edition number:
23/17
Publication date:
07/06/2017
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995 in respect of which a decision has been taken. Opposition(s) decisions ex European Patent Convention

4

Bulletin Heading:
VB1
Journal edition number:
2015/27
Publication date:
01/07/2015
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

5

Bulletin Heading:
EP3
Journal edition number:
2014/49
Publication date:
03/12/2014
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

6

Bulletin Heading:
EP2
Journal edition number:
2014/35
Publication date:
27/08/2014
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201728
Publication date:
12/07/2017
Description:
Revocation of the European patent

2

Issue number:
201723
Publication date:
07/06/2017
Description:
Opposition Withdrawn

3

Issue number:
201526
Publication date:
24/06/2015
Description:
Opposition procedure started

4

Issue number:
201434
Publication date:
20/08/2014
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201701025A
Date Registered:
03/05/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
08/09/2016
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
900 Euro
Payer:
Master Data Center
Filing date Document type Document Description Number of pages File Type
21/07/2017 Outgoing Correspondence Letter registration deed 1 PDF /5/5/7/9/7/0510179755/docs/ep10179755.3_0_151897l118.pdf
03/05/2017 Request for Change First filed deed 3 PDF /5/5/7/9/7/0510179755/docs/ep10179755.3_3_rfc20170531114444643.pdf
26/11/2014 Outgoing Correspondence Outgoing Letter 1 PDF /5/5/7/9/7/0510179755/docs/ep10179755.3_1_outgoingcorrespondence20141126.pdf
30/10/2014 Incoming Correspondence Paper Other 1 PDF /5/5/7/9/7/0510179755/docs/ep10179755.3_2_incomingcorrespondencepaper20141030.pdf
30/10/2014 Claims Translated claims 1 PDF /5/5/7/9/7/0510179755/docs/ep10179755.3_4_claims20141030.pdf